Singapore markets closed

Heron Therapeutics, Inc. (HRTX)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
11.89+0.11 (+0.98%)
As of 3:19PM EDT. Market open.
Currency in USD
Earnings estimateCurrent qtr. (Sep 2021)Next qtr. (Dec 2021)Current year (2021)Next year (2022)
No. of analysts5566
Avg. Estimate-0.62-0.63-2.44-1.62
Low estimate-0.68-0.74-2.58-2.3
High estimate-0.56-0.53-2.29-1.11
Year ago EPS-0.64-0.68-2.5-2.44
Revenue estimateCurrent qtr. (Sep 2021)Next qtr. (Dec 2021)Current year (2021)Next year (2022)
No. of analysts5566
Avg. Estimate25.51M31.85M99.34M188.54M
Low estimate24.25M25.82M92.54M146M
High estimate26.3M35.01M103.69M257.2M
Year ago salesN/A20.61M88.64M99.34M
Sales growth (year/est)N/A54.60%12.10%89.80%
Earnings history29/09/202030/12/202030/03/202129/06/2021
Est. EPS-0.63-0.65-0.57-0.55
Actual EPS-0.64-0.68-0.58-0.62
Difference-0.01-0.03-0.01-0.07
Surprise %-1.60%-4.60%-1.80%-12.70%
EPS trendCurrent qtr. (Sep 2021)Next qtr. (Dec 2021)Current year (2021)Next year (2022)
Current estimate-0.62-0.63-2.44-1.62
7 days ago-0.62-0.63-2.44-1.62
30 days ago-0.58-0.55-2.28-1.3
60 days ago-0.54-0.48-2.14-1.03
90 days ago-0.54-0.48-2.14-1.03
EPS revisionsCurrent qtr. (Sep 2021)Next qtr. (Dec 2021)Current year (2021)Next year (2022)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesHRTXIndustrySector(s)S&P 500
Current qtr.3.10%N/AN/AN/A
Next qtr.7.40%N/AN/AN/A
Current year2.40%N/AN/AN/A
Next year33.60%N/AN/AN/A
Next 5 years (per annum)47.50%N/AN/AN/A
Past 5 years (per annum)-43.36%N/AN/AN/A